Members |
targetComponentId |
Anti-criminal psychotherapy NOS (regime/therapy) |
Anti-criminal psychotherapy NOS |
Anti-criminal psychotherapy NOS |
Anti-criminal psychotherapy NOS (regime/therapy) |
Anti-gliadin IgA level |
Gliadin antibody, IgA measurement |
Anti-gliadin IgA level |
Gliadin antibody, IgA measurement |
Anti-gliadin IgA level |
Gliadin antibody, IgA measurement |
Anti-gliadin IgG level |
Gliadin antibody, IgG measurement |
Anti-gliadin IgG level |
Gliadin antibody, IgG measurement |
Anti-gliadin IgG level |
Gliadin antibody, IgG measurement |
Anti-gliadin antibody level |
Gliadin antibody measurement |
Anti-gliadin IgA antibody level |
Gliadin antibody, IgA measurement |
Anti-gliadin IgG antibody level |
Gliadin antibody, IgG measurement |
Anti-hemoglobin antibody level |
Anti-haemoglobin antibody measurement |
Anti-hepatitis B immunoglobulin given |
immunoglobuline anti-hépatite B administrée |
Anti-hyaluronidase |
Hyaluronidase antibody |
Anti-inflammat. light therapy |
Light therapy for inflammation (procedure) |
Anti-inflammatory agent (product) |
agent anti-inflammatoire |
Anti-inflammatory agent (substance) |
agent anti-inflammatoire |
Anti-liver-kidney microsomal antibody level |
Measurement of liver and kidney microsomal antibody (procedure) |
Anti-myocardium antibody |
Cardiac muscle antibody (substance) |
Anti-neutrophil cytoplasmic antibody level |
Antineutrophil cytoplasmic antibody measurement |
Anti-neutrophil cytoplasmic antibody negative |
Anti-neutrophil cytoplasmic antibody negative |
Anti-nuclear IgG antibody level |
Anti-nuclear IgG antibody level |
Anti-nuclear IgG antibody level |
Anti-nuclear IgG antibody level |
Anti-nuclear IgM antibody level |
Anti-nuclear IgM antibody level |
Anti-nuclear IgM antibody level |
Anti-nuclear IgM antibody level |
Anti-nuclear factor level (procedure) |
Antinuclear antibody measurement (procedure) |
Anti-nuclear factor level |
Antinuclear antibody measurement (procedure) |
Anti-nuclear factor level |
Antinuclear antibody measurement (procedure) |
Anti-nuclear factor weakly positive |
Anti-nuclear factor weakly positive |
Anti-nuclear: ([factor] or [antibody] & level) |
Antinuclear antibody |
Anti-phosphatidylglycerol antibody |
Phosphatidyl glycerol antibody (substance) |
Anti-rabies immunoglobulin injection |
Anti-rabies immunoglobulin injection |
Anti-staph. hemolysin titer |
Anti-staphylococcal haemolysin titre measurement |
Anti-streptokinase |
Streptokinase antibody |
Anti-suicide psychotherapy |
Anti-suicide psychotherapy (regime/therapy) |
Anti-suicide psychotherapy NOS |
Anti-suicide psychotherapy NOS (regime/therapy) |
Anti-suicide psychotherapy NOS (regime/therapy) |
Anti-suicide psychotherapy NOS |
Anti-testes antibody level (procedure) |
Measurement of testis antibody (procedure) |
Anti-tissue transglutaminase level (procedure) |
Anti-tissue transglutaminase level |
Anti-tissue transglutaminase level (procedure) |
Anti-tissue transglutaminase level |
Anti-tuberculous drug reaction |
Antituberculous drug adverse reaction |
Anti-tuberculous drug reaction |
Antituberculous drug adverse reaction |
Anti-varic-Zoster immunoglob (& injection) |
VarIg varicella immunoglobulin unspecified |
Anti-varicella-zoster ig injection (product) |
VarIg varicella immunoglobulin unspecified |
Antianemia agent (substance) |
hématinique |
Antianginal therapy (procedure) |
Antianginal therapy |
Antianginal therapy |
Antianginal therapy |
Antibacterial drugs (substance) |
médicament antibactérien |
Antibiotic antifungal adverse reaction |
Antifungal drug adverse reaction |
Antibiotic antituberculosis drug |
Medicinal product acting as antitubercular agent (product) |
Antibiotic prophylaxis not recommended |
Antibiotic prophylaxis not recommended |
Antibiotic prophylaxis not recommended |
Antibiotic prophylaxis not recommended |
Antibiotic prophylaxis recommended |
Antibiotic prophylaxis recommended |
Antibiotic prophylaxis recommended |
Antibiotic prophylaxis recommended |
Antibody class (substance) |
Immunoglobulin isotype |
Antibody constant region |
Immunoglobulin, constant region |
Antibody hypervariable region |
Immunoglobulin, hypervariable region |
Antibody studies |
Antibody studies |
Antibody titer raized [D] |
Antibody titre above reference range |
Antibody to SCL-70 |
Topoisomerase-1 antibody |
Antibody to extractable nuclear antigen typing (finding) |
Antibody to extractable nuclear antigen measurement |
Antibody to extractable nuclear antigen typing |
Antibody to extractable nuclear antigen measurement |
Antibody to extractable nuclear antigen typing |
Antibody to extractable nuclear antigen measurement |
Antibody to nuclear RNP measurement |
RNP antibody measurement |
Antibody to ribosomal RNP measurement (procedure) |
RNP antibody measurement |
Antibody variable region |
Immunoglobulin, variable region |
Immunoglobulin A (IgA) antibody |
Immunoglobulin A (substance) |
Immunoglobulin D (IgD) antibody |
Immunoglobulin D |
Immunoglobulin E (IgE) antibody |
Immunoglobulin E |
Immunoglobulin G (IgG) antibody |
Immunoglobulin G (substance) |
Immunoglobulin M (IgM) antibody |
Immunoglobulin M (substance) |
Anticholinergic premedications (product) |
Product containing acetylcholine receptor antagonist (product) |
Anticholinesterase overdose of undetermined intent |
Anticholinesterase overdose |
Anticholinesterase poisoning of undetermined intent |
Poisoning by anticholinesterase |
Anticoagulant therapy |
Anticoagulant therapy |
Anticonvulsive therapy |
Anticonvulsant therapy |
Antidepressant drug (substance) |
Medicinal product acting as antidepressant agent (product) |
Antidiabetic agent (product) |
préparation antidiabétique |
Antidiarrheal adsorbent mixture (product) |
agent antidiarrhéique |
Antidiarrheal antimotility drugs (product) |
agent antidiarrhéique |
Antidiarrheal drugs - chronic treatment (product) |
agent antidiarrhéique |
Antidiuretic hormone allergy |
Allergy to antidiuretic hormone |
bas anti-embolie |
bas anti-thrombose |
Antiestrogen |
Estrogen receptor antagonist |
Antigen level |
Antigen assay |
Antigen level (procedure) |
Antigen assay |
Antigen level (procedure) |
Antigen assay |
Antigen of Plasmodium (substance) |
Plasmodium antigen |
Antigen of human leukocyte Cw10(w3) (substance) |
Human leukocyte antigen Cw10(w3) |
Antigen of human leukocyte Cw9(w3) (substance) |
Human leucocyte antigen Cw9(w3) |
Antigen test |
Antigen test |
Antigen test |
Antigen test |
Antigen-free surroundings |
Antigen-free surroundings |
Lyme antigen |
Lyme antigen |
Antihemophilic factor transfusion |
Antihaemophilic factor transfusion |
Antihelminth drug prophylaxis |
Administration of prophylactic antihelminth (procedure) |
Antihistamines (product) |
Product containing histamine receptor antagonist (product) |
Antihypertensive overdose of undetermined intent |
Antihypertensive overdose |
Antihypertensive therapy (procedure) |
Antihypertensive therapy |
Antihypertensive therapy |
Antihypertensive therapy |
Antilean piculet |
Nesoctites micromegas (organism) |